CERTARA INC. - COMMON STOCK

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions

23 6 2021 19:00:00 提供 Nasdaq GlobeNewswire

Certara Appoints Dr. Carol Gallagher as New Independent Board Member

14 6 2021 08:00:01 提供 Nasdaq GlobeNewswire

Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

20 5 2021 08:00:01 提供 Nasdaq GlobeNewswire

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

13 5 2021 08:00:01 提供 Nasdaq GlobeNewswire

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

06 5 2021 16:15:00 提供 Nasdaq GlobeNewswire

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

04 5 2021 18:15:00 提供 Nasdaq GlobeNewswire